HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Morimoto Selected Research

Platelet-Derived Growth Factor

11/2017Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Morimoto Research Topics

Disease

4Neoplasms (Cancer)
05/2022 - 11/2017
2Neoplasm Metastasis (Metastasis)
05/2022 - 10/2021
1Hemorrhage
06/2024
1Fibrosis (Cirrhosis)
05/2022
1Renal Cell Carcinoma (Grawitz Tumor)
05/2022
1Breast Neoplasms (Breast Cancer)
10/2021
1Lung Neoplasms (Lung Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

3BiglycanIBA
05/2022 - 01/2021
1Therapeutic UsesIBA
05/2022
1LipidsIBA
05/2022
1Small Interfering RNA (siRNA)IBA
05/2022
1Angiopoietin-2IBA
10/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1Proteoglycans (Proteoglycan)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1platelet-derived growth factor AIBA
11/2017
1Fluorouracil (Carac)FDA LinkGeneric
11/2017
1Aldehyde DehydrogenaseIBA
11/2017
1Platelet-Derived Growth FactorIBA
11/2017
1Conditioned Culture MediaIBA
11/2017

Therapy/Procedure

1Laparotomy
06/2024
1Thoracotomy
06/2024
1Therapeutics
05/2022